The journal einstein (São Paulo) – e-ISSN 2317-6385 is dedicated to dissemination of high-quality scientific content that advances our understanding of human disease with the goal of improving prevention, care, diagnostics and treatment of patients globally.
Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16
We would like to update the readership of (São Paulo) on the information given in page 6, regarding hyaluronidase facilitated subcutaneous immunoglobulin, in the article entitled II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies published in this journal in volume 15 issue 1, 2017.(
)
[…]
Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16
GoudourisES, SilvaAMR, OuricuriAL, GrumachAS, Condino-NetoA, Costa-CarvalhoBT, PrandoCCM, et al. Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16. Einstein (São Paulo) 2017;15(4):522. https://doi.org/10.1590/S1679-45082017CE4250
Goudouris,Ekaterini Simões; Silva,Almerinda Maria do Rego; Ouricuri,Aluce Loureiro; Grumach,Anete Sevciovic; Condino-Neto,Antonio; Costa-Carvalho,Beatriz Tavares; Prando,Carolina Cardoso de Mello; Kokron,Cristina Maria; Vasconcelos,Dewton de Moraes; Tavares,Fabíola Scancetti; Segundo,Gesmar Rodrigues Silva; Barreto,Irma Cecília Douglas Paes; Dorna,Mayra de Barros; Barros,Myrthes Anna Maragna Toledo; Forte,Wilma Carvalho Neves. Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16. Einstein (São Paulo), v. 15, n. 4, p. 522-522, Oct. 2017. https://doi.org/10.1590/S1679-45082017CE4250
Goudouris,E.S., Silva,A.M.R., Ouricuri,A.L., Grumach,A.S., Condino-Neto,A., Costa-Carvalho,B.T., Prando,C.C.M., Kokron,C.M., Vasconcelos,D.M., Tavares,F.S., Segundo,G.R.S., Barreto,I.C.D.P., Dorna,M.B., Barros,M.A.M.T., & Forte,W.C.N. (2017). Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16. Einstein (São Paulo),15(4), 522-522. https://doi.org/10.1590/S1679-45082017CE4250
Goudouris,Ekaterini Simões and Silva,Almerinda Maria do Rego and Ouricuri,Aluce Loureiro and Grumach,Anete Sevciovic and Condino-Neto,Antonio and Costa-Carvalho,Beatriz Tavares and Prando,Carolina Cardoso de Mello and Kokron,Cristina Maria and Vasconcelos,Dewton de Moraes and Tavares,Fabíola Scancetti and Segundo,Gesmar Rodrigues Silva and Barreto,Irma Cecília Douglas Paes and Dorna,Mayra de Barros and Barros,Myrthes Anna Maragna Toledo and Forte,Wilma Carvalho Neves. Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16. Einstein (São Paulo) [online]. 2017, vol. 15, n. 4, [cited 2025-09-05], pp.522-522. Available from: <https://journal.einstein.br/article/comment-to-ii-brazilian-consensus-on-the-use-of-human-immunoglobulin-in-patients-with-primary-immunodeficiencies-einstein-sao-paulo-20171511-16/>. ISSN 1679-4508. https://doi.org/10.1590/S1679-45082017CE4250
Figure 5
Risk of bias assessment of non-RCTs using the ROBINS-I tool
Non-RCT, nonrandomized controlled trial; ROBINS-I, Risk of Bias in Non-Randomized Studies-of Interventions
